Alembic Pharmaceuticals announced that it has received final approval from US Food & Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Icatibant injection, single-dose prefilled syringe.
| Subscribe To Our Free Newsletter |
